Fluidigm’s New Digital Array Delivers Peak Levels of Throughput for Digital PCR

Today Fluidigm introduced its new 48.770 Digital Array, the highest density commercially available integrated fluidic circuit (IFC) ever. This IFC is capable of testing up to 48 individual samples at a time and automatically partitioning each of the samples into separate sets of 770 reaction chambers – delivering a total of 36,960 simultaneous digital PCR [...]

New Global Study on Medication Errors Supports the ValiMed(TM) International Expansion Initiatives

An International Study of 27 Countries Concluded That Errors in the Administration of Injected Medications Are a Serious Safety Problem -- ValiMed(TM) by CDEX Is Addressing This Problem in a Growing Number of Hospitals Worldwide TUCSON, AZ--Mar 16, 2009 -- CDEX Inc. (OTC BB:CEXI.OB - News). A March 12, 2009 report published in the British [...]

febit’s Automated Sequence Capture for Next-Generation Sequencing Paves the Way for Personalized Medicine

febit today announced the official launch of its new sequence capture technology Hybselect. In several biomedical studies of early access customers over the past months, HybSelect demonstrated superb enrichment factors and deep sequencing coverage for a broad range of human genes and genomic regions. As the first sequence capture technology combining outstanding enrichment and walk-away [...]

Sigma-Aldrich Acquires Sigal Ltda and Expands Operations in Chile

ST. LOUIS, March 13 -- Sigma-Aldrich (Nasdaq: SIAL) today announced that it has expanded its presence in the Republic of Chile to directly serve research and manufacturing customers throughout the country. The Company has acquired Sigal Ltda, its primary distributor in Chile, and established Sigma-Aldrich Quimica Ltda to provide a foundation for future growth in [...]

ChromaTOF® 4.20 Now Available

St. Joseph, Michigan-LECO has introduced ChromaTOF 4.20, the latest version of its exclusive software, at Pittcon 2009. This dynamic software package integrates acquisition, processing, and reporting tools into one total data solution. Working versions of the software will be demonstrated at the show, where users can obtain hands-on experience with these new features: o Enhanced [...]

AnaSpec Signs Distribution Agreement with BioPike, LLC

San Jose, CA, March 13, 2009 --(PR.com)-- AnaSpec, Inc. and BioPike, LLC today announced a non-exclusive distributor agreement that will allow BioPike, LLC to distribute AnaSpec’s catalog and custom products throughout China. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec is pleased to partner with BioPike, LLC to expand the availability of our [...]

Millipore Corporation and CXR Biosciences Introduce Toxicity Reporter Assay Panel

Billerica, MA and Dundee, UK, March 13, 2009 -- Millipore Corporation (Billerica, MA) and CXR Biosciences® (Dundee, UK) today launched ToxReporter™, a new panel of engineered cell lines and assays that can screen compounds for toxicity early in the drug discovery process. Toxicity is one of the primary reasons why potential drug candidates fail during [...]

Nanogen Receives NASDAQ Delisting Notice

SAN DIEGO--Nanogen, Inc. (Nasdaq: NGEN), developer of in vitro diagnostic products, announced that on March 12, 2009 the company received a Staff Determination letter from NASDAQ (the “Delisting Notice”) indicating that the Company is subject to delisting proceedings due to non-payment of certain outstanding fees as required for continuing listing set forth in NASDAQ’s Marketplace [...]

PAC Appoints New President

Houston, Texas - PAC is pleased to announce today the appointment of Jeroen Schmits as the company's President. Jeroen Schmits lead several industrial companies in the US and other areas, recently he was CEO of ANCA Pty Ltd, a Melbourne Australia based global machine tool manufacturer. Prior to that, he was President of two Dover [...]

Advance Nanotech’s Owlstone Announces First Pharmaceutical Industry Order

NEW YORK, March 12 -- Advance Nanotech, Inc., (OTC Bulletin Board: AVNA), today announced that the Company's majority owned subsidiary, Owlstone Nanotech, Inc., has received an initial purchase order from Genzyme Corporation one of the world's leading biotechnology companies, for its Lonestar detection system. Bret Bader, CEO of Advance Nanotech, said, "As a result of [...]

Access IBO on Knowledge Center